Capricor Investors Urged to Act on Securities Class Action Lawsuit Before Deadline Approaches #USA #New_York #Securities_Class_Action #Faruqi_&_Faruqi #Capricor_Therapeutics
@newsen.bsky.social
@newsen.bsky.socialCapricor Investors Urged to Act on Securities Class Action Lawsuit Before Deadline Approaches #USA #New_York #Securities_Class_Action #Faruqi_&_Faruqi #Capricor_Therapeutics
@newsen.bsky.socialInvestors Urged to Act Following Capricor Therapeutics Lawsuit Filing #USA #San_Diego #Lawsuit #investors #Capricor_Therapeutics
@newsen.bsky.socialCapricor Therapeutics Investors Eye Class Action Ahead of September Deadline #United_States #San_Francisco #FDA #Securities_Class_Action #Capricor_Therapeutics
@newsen.bsky.socialCapricor Therapeutics Faces Class Action Lawsuit Over Securities Fraud Claims as Deadline Approaches #United_States #New_York #Class_Action #Securities_Fraud #Capricor_Therapeutics
@newsen.bsky.socialCapricor Therapeutics Investors Have Until September 28 for Class Action Participation #United_States #Class_Action #San_Francisco #deramiocel #Capricor_Therapeutics
@newsen.bsky.socialCapricor Therapeutics Faces Class Action: Key Dates for Investors to Note #United_States #New_York #Kahn_Swick #class_action_lawsuit #Capricor_Therapeutics
@newsen.bsky.socialCapricor Therapeutics Faces Class Action Lawsuit Over Securities Violations #United_States #Class_Action #Los_Angeles #Securities_Laws #Capricor_Therapeutics
@newsen.bsky.socialInvestment Opportunities in Capricor Therapeutics' Securities Fraud Lawsuit Led by SBS Law Firm #United_States #Los_Angeles #Securities_Fraud #Capricor_Therapeutics #SBS_Law_Firm
@newsen.bsky.socialHagens Berman Informs Investors of FDA Review Extension for Capricor Therapeutics Amid Legal Proceedings #United_States #San_Francisco #Hagens_Berman #deramiocel #Capricor_Therapeutics
@newsen.bsky.socialInvestors of Capricor Therapeutics Seek Leadership in Class Action by September 28, 2026 #United_States #Robbins_Geller #San_Diego #class_action_lawsuit #Capricor_Therapeutics
@newsen.bsky.socialFaruqi & Faruqi Law Firm Calls for Capricor Investors to Take Action Before Class Action Deadline #USA #New_York #Faruqi_&_Faruqi #Investors_Alert #Capricor_Therapeutics
@newsen.bsky.socialCapricor Therapeutics Investors Urged to Join Class Action Lawsuit By Sept 28 Deadline #USA #Class_Action #San_Francisco #securities_lawsuit #Capricor_Therapeutics
@newsen.bsky.socialImportant Updates for Capricor Therapeutics Investors Amid Class Action Lawsuit #USA #New_York #Levi_&_Korsinsky #Capricor_Therapeutics #CAPR_lawsuit
@newsen.bsky.socialCapricor Therapeutics Investors Alert: Join Securities Fraud Class Action Before Deadline #USA #New_York #Securities_Fraud #Rosen_Law_Firm #Capricor_Therapeutics
@newsen.bsky.socialCapricor Therapeutics Faces Class Action Lawsuit After Major Stock Plummet Linked to Clinical Data Issues #United_States #California #Securities_Fraud #deramiocel #Capricor_Therapeutics
@newsen.bsky.socialCapricor Therapeutics Class Action: What Investors Need to Know #New_York #Investor_Rights #securities_litigation #Capricor_Therapeutics
@newsen.bsky.socialClass Action Lawsuit Filed Against Capricor Therapeutics Amid Allegations of Securities Fraud #United_States #New_York #Pomerantz_LLP #Capricor_Therapeutics #CAPR
@newsen.bsky.socialCapricor Therapeutics Faces Class Action Lawsuit Amid Investment Concerns and Regulatory Challenges #USA #San_Diego #Class_Action #Securities_Fraud #Capricor_Therapeutics
@newsen.bsky.socialClass Action Lawsuit Against Capricor Therapeutics: What Investors Need to Know #United_States #Los_Angeles #securities_lawsuit #DJS_Law_Group #Capricor_Therapeutics
@newsen.bsky.socialCapricor Therapeutics' Investors Have a Chance to Lead Securities Fraud Class Action Lawsuit #United_States #Los_Angeles #Securities_Fraud #Capricor_Therapeutics #SBS_Law